Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Valentina Loi is active.

Publication


Featured researches published by Valentina Loi.


Transplantation | 2017

Outcomes of Pregnancies after Kidney Transplantation: Lessons Learned from CKD. A Comparison of Transplanted, Nontransplanted Chronic Kidney Disease Patients and Low-Risk Pregnancies: A Multicenter Nationwide Analysis

Giorgina Barbara Piccoli; Gianfranca Cabiddu; Rossella Attini; Martina Gerbino; Paola Todeschini; Maria Luisa Perrino; Ana Maria Manzione; Gian Benedetto Piredda; Elisa Gnappi; Flavia Caputo; Giuseppe Montagnino; Vincenzo Bellizzi; Pierluigi Di Loreto; Francesca Martino; Domenico Montanaro; Michele Rossini; Santina Castellino; Marilisa Biolcati; Federica Fassio; Valentina Loi; Silvia Parisi; Elisabetta Versino; Antonello Pani; Tullia Todros

Background Kidney transplantation (KT) may restore fertility in chronic kidney disease (CKD). The reasons why maternofetal outcomes are still inferior to the overall population are only partially known. Comparison with the CKD population may offer some useful insights for management and counselling. Aim of this study was to analyse the outcomes of pregnancy after KT, compared with a large population of nontransplanted CKD patients and with low-risk control pregnancies, observed in Italy the new millennium. Methods We selected 121 live-born singletons after KT (Italian study group of kidney in pregnancy, national coverage about 75%), 610 live-born singletons in CKD, and 1418 low-risk controls recruited in 2 large Italian Units in the same period (2000-2014). The following outcomes were considered: maternal and fetal death; malformations; preterm delivery; small for gestational age (SGA) baby; need for the neonatal intensive care unit; doubling of serum creatinine or increase in CKD stage. Data were analyzed according to kidney diseases, renal function (staging according to CKD-epidemiology collaboration), hypertension, maternal age, parity, ethnicity. Results Maternofetal outcomes are less favourable in CKD and KT as compared with the low-risk population. CKD stage and hypertension are important determinants of results. Kidney transplantation patients with estimated glomerular filtration rate greater than 90 have worse outcomes compared with CKD stage 1 patients; the differences level off when only CKD patients affected by glomerulonephritis or systemic diseases (“progressive CKD”) are compared with KT. In the multivariate analysis, risk for preterm and early-preterm delivery was linked to CKD stage (2-5 vs 1: relative risk 3.42 and 3.78) and hypertension (RR 3.68 and 3.16) while no difference was associated with being a KT or a CKD patient. Conclusions The maternofetal outcomes in patients with kidney transplantation are comparable with those of nontransplanted CKD patients with similar levels of kidney function impairment and progressive and/or immunologic kidney disease.


Frontiers of Medicine in China | 2017

Exercise-Associated Hyponatremia: 2017 Update

Tamara Hew-Butler; Valentina Loi; Antonello Pani; Mitchell H. Rosner

Exercise-associated hyponatremia (EAH) was initially described in the 1980s in endurance athletes, and work done since then has conclusively identified that overdrinking beyond thirst and non-osmotic arginine vasopressin release are the most common etiologic factors. In recent years, EAH has been described in a broader variety of athletic events and also has been linked to the development of rhabdomyolysis. The potential role of volume and sodium depletion in a subset of athletes has also been described. This review focuses on the most recent literature in the field of EAH and summarizes key new findings in the epidemiology, pathophysiology, treatment, and prevention of this condition.


Nutrients | 2016

Low-Protein Diets in Diabetic Chronic Kidney Disease (CKD) Patients: Are They Feasible and Worth the Effort?

Giorgina Barbara Piccoli; Federica Ventrella; Irene Capizzi; Federica Neve Vigotti; Elena Mongilardi; Giorgio Grassi; Valentina Loi; Gianfranca Cabiddu; Paolo Avagnina; Elisabetta Versino

Low-protein diets (LPDs) are often considered as contraindicated in diabetic patients, and are seldom studied. The aim of this observational study was to provide new data on this issue. It involved 149 diabetic and 300 non-diabetic patients who followed a LPD, with a personalized approach aimed at moderate protein restriction (0.6 g/day). Survival analysis was performed according to Kaplan–Meier, and multivariate analysis with Cox model. Diabetic versus non-diabetic patients were of similar age (median 70 years) and creatinine levels at the start of the diet (2.78 mg/dL vs. 2.80 mg/dL). There was higher prevalence of nephrotic proteinuria in diabetic patients (27.52% vs. 13.67%, p = 0.002) as well as comorbidity (median Charlson index 8 vs. 6 p = 0.002). Patient survival was lower in diabetic patients, but differences levelled off considering only cases with Charlson index > 7, the only relevant covariate in Cox analysis. Dialysis-free survival was superimposable in the setting of good compliance (Mitch formula: 0.47 g/kg/day in both groups): about 50% of the cases remained dialysis-free 2 years after the first finding of e-GFR (estimated glomerular filtration rate) < 15 mL/min, and 1 year after reaching e-GFR < 10 mL/min. In patients with type 2 diabetes, higher proteinuria was associated with mortality and initiation of dialysis. In conclusion, moderately restricted LPDs allow similar results in diabetic and non non-diabetic patients with similar comorbidity.


PLOS ONE | 2017

KIR and their HLA Class I ligands: Two more pieces towards completing the puzzle of chronic rejection and graft loss in kidney transplantation

Roberto Littera; Gianbenedetto Piredda; Davide Argiolas; Sara Lai; Elena Congeddu; Paola Ragatzu; Maurizio Melis; Elisabetta Carta; Maria Benigna Michittu; Donatella Valentini; L Cappai; Rita Porcella; F Alba; Maria Paola Serra; Valentina Loi; R Maddi; Sandro Orru; Giorgio La Nasa; Giovanni Caocci; Roberto Cusano; M Arras; Mauro Frongia; Antonello Pani; Carlo Carcassi

Background Kidney transplantation is a life-saving treatment for patients with end-stage renal disease. However, despite progress in surgical techniques and patient management, immunological rejection continues to have a negative impact on graft function and overall survival. Incompatibility between donors and recipients for human leukocyte antigens (HLA) of the major histocompatibility complex (MHC) generates a series of complex cellular and humoral immune response mechanisms that are largely responsible for rejection and loss of graft function. Within this context, a growing amount of evidence shows that alloreactive natural killer (NK) cells play a critical role in the immune response mechanisms elicited by the allograft. Killer immunoglobulin-like receptors (KIRs) are prominent mediators of NK cell alloreactivity. Methods and findings A cohort of 174 first cadaveric kidney allograft recipients and their donors were selected from a total cohort of 657 transplanted patients for retrospective immunogenetic analyses. Patients with HLA Class II mismatches were excluded. HLA Class I allele frequencies were compared among patients with chronic rejection, patients with stable graft function and a group of 2388 healthy controls. Activating and inhibitory KIR gene frequencies, KIR haplotypes, KIR-HLA ligand matches/mismatches and combinations of recipient KIRs and donor HLA Class I ligands were compared among patients with and without chronic rejection and a group of 221 healthy controls. Patients transplanted from donors homozygous for HLA-C1 antigens had a significantly higher risk for chronic rejection than patients transplanted from donors homozygous or heterozygous for HLA-C2 antigens or with epitopes belonging to the HLA-Bw4 ligand group. The Kaplan-Meier curves obtained by dividing the patients into 3 groups according to the presence or absence of one or both of the combinations of recipient KIRs and donor HLA ligands (rKIR2DL1/dHLA-C2 and rKIR3DL1/dHLA-Bw4) showed a significantly higher cumulative incidence of chronic rejection in the group of patients completely lacking these functional units. These patients showed a progressively stronger decline in modification of diet in renal disease-estimated glomerular filtration rate. Conclusions KIR genotyping should be performed at the time of enrolment of patients on the waiting list for organ transplantation. In our study, a significantly higher risk of chronic rejection after kidney transplantation was observed when recipient (r) and donor (d) pairs completely lacked the two functional rKIR-dHLA ligand combinations rKIR2DL1/dHLA-C2 and rKIR3DL1/dHLA-Bw4. This immunogenetic profile corresponds to low levels of NK cell inhibition. Therefore, patients with this high risk profile could benefit from immunosuppressive therapy aimed at reducing NK-cell cytotoxicity.


BMC Nephrology | 2016

Compliance, illiteracy and low-protein diet: multiple challenges in CKD and a case of self-empowerment

Stefania Maxia; Valentina Loi; Irene Capizzi; Giorgina Barbara Piccoli; Gianfranca Cabiddu; Antonello Pani

BackgroundLow-protein diets (LPD) are an important means of delaying the need for dialysis and attaining a stable metabolic balance in chronic kidney disease (CKD). Many authors consider a low educational level and illiteracy to be adverse features for a good dietary compliance.Case presentationWe report the case of a 77-year old woman, illiterate, affected by advanced CKD (stage 4 according to KDIGO guidelines). She was initially ashamed of her problem and did not declare it, leading to an overzealous reduction in protein intake. However, with her daughter’s help, who translated the dietary prescription into images, she overcame the barrier represented by illiteracy and was able to correctly follow the prescriptions, attaining good kidney function stability and preserving an adequate nutritional status.ConclusionsThe case underlines the importance of a personalized approach to dietary prescriptions and suggests that it is possible to achieve a good compliance to the dietary treatment of CKD also in patients with relevant cultural barriers.


Vegetarian and Plant-Based Diets in Health and Disease Prevention | 2017

Vegetarian and Plant-Based Diets in Pregnancy

Giorgina Barbara Piccoli; Filomena Leone; Rossella Attini; Gianfranca Cabiddu; Valentina Loi; Stefania Maxia; Irene Capizzi; Tullia Todros

Abstract A healthy diet during pregnancy has been recognized for centuries as key for the well-being of the mother and the fetus. Over time, the definition of an ideal diet has progressively switched from a diet at a low-risk of nutritional deficiencies to a diet that reduced the risk of diseases that relates to overeating. The rediscovery of the Mediterranean diet and vegetarian diets has gained a growing interest, mainly because they may protect from the most commonly encountered chronic diseases linked to “overeating” in the developed and developing world, including the array of cardiovascular diseases, diabetes, and obesity. The evidence on advantages and drawbacks of plant-based diets in pregnancy is scant, and heterogeneous also on the account of the link with higher education and health awareness in Western countries, and with poverty in the developing world. However, well-balanced plant-based diets are theoretically welcomed in both settings: they are rarely “too rich” and may protect from overnutrition in high resourced countries, and they are often more affordable in low-resourced countries. The present review contextualizes vegetarian/vegan diets in four situations: the “healthy and wealthy,” who choose them in the Western words, the “poor and obliged” in low-resourced settings, the “nutritionally disturbed,” on the account of the link between nutritional disturbances and plant-based diets in the Western world, and the “sick and controlled,” i.e., the specific experience on protein-restricted diets in patients with chronic kidney diseases. Overall, well-balanced, varied, and controlled, plant-based diets in pregnancy are nutritionally safe, and they are not associated with clinical problems in either mother nor child, in health and disease, provided they are varied and balanced enough and attention is paid to cover the nutritional requirements (in particular, vitamin B 12 , vitamin D, iron, and zinc).


Journal of Nephrology | 2016

A best practice position statement on pregnancy in chronic kidney disease: the Italian Study Group on Kidney and Pregnancy

Gianfranca Cabiddu; Santina Castellino; Giuseppe Gernone; Domenico Santoro; Gabriella Moroni; Michele Giannattasio; Gina Gregorini; Franca Giacchino; Rossella Attini; Valentina Loi; Monica Limardo; Linda Gammaro; Tullia Todros; Giorgina Barbara Piccoli


BMC Nephrology | 2016

Vegan-vegetarian low-protein supplemented diets in pregnant CKD patients: fifteen years of experience

Rossella Attini; Filomena Leone; Silvia Parisi; Federica Fassio; Irene Capizzi; Valentina Loi; Loredana Colla; Maura Rossetti; Martina Gerbino; Stefania Maxia; Maria Grazia Alemanno; Fosca Minelli; Ettore Piccoli; Elisabetta Versino; Marilisa Biolcati; Paolo Avagnina; Antonello Pani; Gianfranca Cabiddu; Tullia Todros; Giorgina Barbara Piccoli


Nephrology Dialysis Transplantation | 2015

Children of a lesser god or miracles? An emotional and behavioural profile of children born to mothers on dialysis in Italy: a multicentre nationwide study 2000–12

Giorgina Barbara Piccoli; Valentina Postorino; Gianfranca Cabiddu; Sara Ghiotto; Gabriella Guzzo; Simona Roggero; Eleonora Manca; Rosalba Puddu; F. R. Meloni; Rossella Attini; Paolo Moi; Bruna Guida; Stefania Maxia; Antonio Piga; Luigi Mazzone; Antonello Pani; Santina Castellino; Giuseppe Gernone; Santo Calabria; Marco Galliani; Gianfranco Manisco; Massimo di Tullio; Luigi Vernaglione; Maria Grazia Chiappini; Emanuela Proietti; Stefano Saffiotti; Concetta Gangeni; Chiara Brunati; Alberto Montoli; Ciro Esposito


Current Hypertension Reports | 2016

Hypertension in CKD Pregnancy: a Question of Cause and Effect (Cause or Effect? This Is the Question)

Giorgina Barbara Piccoli; Gianfranca Cabiddu; Rossella Attini; Silvia Parisi; Federica Fassio; Valentina Loi; Martina Gerbino; Marilisa Biolcati; Antonello Pani; Tullia Todros

Collaboration


Dive into the Valentina Loi's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge